Streetbeat News

Products Services

SXTP

60 Degrees Pharmaceuticals has partnered with Tufts Medical Center to conduct the first clinical trial evaluating tafenoquine for treating babesiosis in humans. Enrollment will start on June 13, 2024, in Boston, with plans to expand recruitment to other hospitals in the Northeast U.S.

Portfolio Pulse from Benzinga Newsdesk

May 30, 2024 | 12:01 pm

ORCL

Oracle Corporation (NYSE:ORCL) shares are trading lower in the premarket session on Thursday following the announcement of plans to open two Oracle Cloud Regions in Morocco. These regions aim to support digital transformation in Africa and modernize Moroccan public services.

Portfolio Pulse from Nabaparna Bhattacharya

May 30, 2024 | 12:00 pm

J

Jacobs has secured a contract from the City of Hamilton, Ontario, Canada, to provide engineering services for the Phase 2 expansion of the Woodward Avenue Wastewater Treatment Plant.

Portfolio Pulse from Benzinga Newsdesk

May 30, 2024 | 11:47 am

XERS

Xeris reported positive topline results from its Phase 2 study of XP-8121 for hypothyroidism treatment, showing higher treatment satisfaction and preference for SC administration. An FDA interaction for Phase 3 is expected by year-end.

Portfolio Pulse from Benzinga Newsdesk

May 30, 2024 | 11:41 am

IXHL

Incannex Healthcare has started dosing in its Phase 2/3 clinical trial for IHL-42X, a treatment for obstructive sleep apnea.

Portfolio Pulse from Benzinga Newsdesk

May 30, 2024 | 11:33 am

BTCUSD

ETHUSD

XRPUSD

Experts weigh in on the potential impact of former President Donald Trump's return to power on the cryptocurrency market, particularly Bitcoin and Ethereum. Key predictions include possible personnel changes at the SEC, executive orders favoring crypto, and significant political resistance, especially from Senator Elizabeth Warren.

Portfolio Pulse from Aniket Verma

May 30, 2024 | 11:30 am

VINO

Gaucho Group Holdings, Inc (NASDAQ:VINO) has launched a new fintech mortgage lending division, Gaucho Open Asset Lending (GOAL), to provide self-financed mortgage options for its luxury vineyard real estate project, Algodon Wine Estates. The company aims to generate $80M-$100M in revenue from vineyard lot sales and plans to expand GOAL's services across Argentina.

Portfolio Pulse from Anusuya Lahiri

May 30, 2024 | 11:30 am

VINO

Gaucho Holdings has announced the launch of a new fintech financing arm called 'GOAL,' which aims to expand beyond the company's assets and potentially disrupt traditional lending in Argentina.

Portfolio Pulse from Benzinga Newsdesk

May 30, 2024 | 11:30 am

VINO

Gaucho Holdings has announced the expansion of its business with the launch of the Gaucho Open Asset Lending Division. This new division aims to provide asset-backed loans, leveraging the company's existing assets to generate additional revenue streams.

Portfolio Pulse from Benzinga Newsdesk

May 30, 2024 | 11:30 am

CDNA

CareDx will present new data at the 2024 American Transplant Congress, featuring 36 oral presentations and posters, and a symposium. The findings will highlight innovative approaches, including AI integration, and the clinical utility of CareDx's solutions in kidney, heart, and lung transplantation.

Portfolio Pulse from Benzinga Newsdesk

May 30, 2024 | 11:28 am